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Aims To test the hypothesis that Qr in V1 is a predictor of pulmonary embolism, right
ventricular strain, and adverse clinical outcome.
Methods and Results ECG’s from 151 patients with suspected pulmonary embolism
were blindly interpreted by two observers. Echocardiography, troponin I, and pro-
brain natriuretic peptide levels were obtained in 75 patients with pulmonary embo-
lism. Qr in V1 (14 vs 0 in controls; p<0.0001) and ST elevation in V1 ≥1 mV (15 vs 1 in
controls; p=0.0002) were more frequently present in patients with pulmonary embo-
lism. Sensitivity and specificity of Qr in V1 and T wave inversion in V2 for predicting
right ventricular dysfunction were 31/97% and 45/94%, respectively. Three of five
patients who died in-hospital and 11 of 20 patients with a complicated course,
presented with Qr in V1. After adjustment for right ventricular strain including ECG,
echocardiography, pro-brain natriuretic peptide and troponin I levels, Qr in V1 (OR
8.7, 95%CI 1.4–56.7; p=0.02) remained an independent predictor of adverse outcome.
Conclusions Among the ECG signs seen in patients with acute pulmonary embolism, Qr
in V1 is closely related to the presence of right ventricular dysfunction, and is an
independent predictor of adverse clinical outcome.
© 2003 The European Society of Cardiology. Published by Elsevier Science Ltd. All
rights reserved.
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Introduction
Electrocardiography (ECG) in patients with pul-
monary embolism may show several abnormalities
related to right ventricular strain. Many ECG signs
are more frequent in patients with pulmonary
embolism compared to those in whom pulmonary
embolism is suspected but excluded, but none of
the different ECG signs have been shown to be
sufficiently specific to establish the diagnosis. In
combination with a high clinical pretest probability
or echocardiographic signs of right ventricular dys-
function, accuracy of ECG to diagnose pulmonary
embolism may be improved.1,2 On the other hand,
ECG may be entirely normal in up to 20% of patients
with pulmonary embolism resulting in a low sensi-
tivity for the exclusion of the diagnosis.3 However,
ECG is obtained in almost all patients who present
with dyspnoea, chest pain or syncope. Thus, its
diagnostic value for patients with suspected pulmo-
nary embolism is important even in the era of
modern diagnostic strategies including spiral com-
puted tomography (CT) and echocardiography.
Many years ago, Weber and Phillips observed a
pseudoinfarction pattern with Q waves in lead V1 in
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10 of 60 patients with pulmonary embolism.3 This
pattern was also found in 11 of 90 patients with
pulmonary embolism in a later study.4 It is assumed
that this sign is caused by massive right-heart
dilatation rotating the QRS vector away from the
V1-position resulting in a Q wave. We aimed to test
the hypothesis that Qr in V1 is a the predictor of
pulmonary embolism, right ventricular strain, and
adverse clinical outcome.
Methods
Patients
A total of 151 consecutive patients from a diagnos-
tic and treatment study with suspected sympto-
matic pulmonary embolism from the emergency
department were enrolled in the present analysis.5
The study protocol was approved by the local
ethics committee, and written informed consent
was obtained from all patients.
Diagnostic strategy
The diagnostic strategy included D-dimer testing,
assessment of clinical pretest probability according
to the Wells criteria,6 and spiral computed tomog-
raphy (CT). In 30 patients with a D-dimer level
below the cut-off value (500 ng/ml) and a low
pretest probability, pulmonary embolism was ex-
cluded. In the remaining 121 patients with elevated
D-dimer, including two patients with a negative
D-dimer but a moderate or high pretest probability,
spiral CT was performed. Pulmonary embolism was
confirmed in 75 patients by spiral CT. In 34 patients
with a negative spiral CT and a low clinical pretest
probability, pulmonary embolism was excluded. In
12 patients with a negative spiral CT but a moder-
ate or high pretest probability, further diagnostic
tests were obtained: ventilation perfusion scan in
six, compression sonography of the leg veines in
four, and pulmonary angiography in two patients.
According to the strategy, 75 patients were positive
and 76 negative for pulmonary embolism.
Discharge diagnoses of the 76 patients without
pulmonary embolism were musculoskeletal pain
(n=22), pneumonia (n=17), chronic obstructive lung
disease (n=15), congestive heart failure (n=14),
acute coronary syndrome (n=2), pericardial effu-
sion (n=2), aortic dissection (n=2), and sepsis (n=2).
Three-month follow-up was performed in the 76
patients with initially negative test results. There
was no venous thromboembolism among these
patients, including 70 patients who received no
anticoagulation during follow-up.
Laboratory tests
D-dimer was measured in all patients on admission
using VIDAS D-dimer (bio-Me´rieux, France), a quan-
titative enzyme-linked immunoassay automated
on a VIDAS immunoanalyzer.7 Troponin I and N-
terminal pro brain natriuretic peptid (proBNP) levels
were taken in all 75 patients with pulmonary embo-
lism on admission. Troponin I was measured using
a microparticle enzyme immunoassay (Abbott,
USA), and proBNP with the Elecsys 2010 immuno-
assay analyzer (Roche, Germany). A Troponin I level
≥0.6 ng/ml was considered to be elevated.8
Spiral computed tomography (CT)
Pulmonary embolism was diagnosed by spiral CT
when there was at least one intravascular filling
defect in a pulmonary artery using a standard pro-
tocol.9 A single-slice CT scanner Somatom Plus 4
UFC (Siemens, Erlangen, Germany) was used in 80
patients, and a multislice scanner Asteion MS
(Toshiba, Tokyo, Japan) in 41 patients. The scan
protocol with the single slice scanner included early
arterial phase scanning 15–20 s after power-
injection of a bolus of 120 ml of a contrast agent
with 300 mg/ml iodine content using a 3 mm
collimation, pitch 1.5, and a 2 mm reconstruction
interval with coverage of the lung vasculature,
followed by a second portal venous phase scan
with 8 mm collimation and 8 mm reconstruction
interval, pitch 1.5, covering the entire chest. The
standard protocol of the multislice scanner in-
cluded arterial phase scanning 20 s after power-
injection of a 120 ml bolus of the contrast agent
with 4|31 mm collimation, pitch 5.5/4 and 1 mm
reconstruction interval with coverage of the entire
chest. The interobserver agreement between two
radiologists for spiral CT results was 97% (kappa
0.95, p<0.0001).
Transthoracic echocardiography
Echocardiography was performed in all patients
with pulmonary embolism using an Acuson
SequoiaTM C256 system (Mountain View, California,
USA) with a 3.5 MHz probe and 3-lead electro-
cardiographic monitoring within 4 h after admis-
sion. Echocardiographic off-line analysis by
soft-copy reading was performed by a cardiologist
who was unaware of clinical data. Systolic right
ventricular dysfunction was diagnosed in the
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presence of moderately to severely depressed right
ventricular free wall kinesis.10,11
Electrocardiography (ECG)
Twelve-lead ECG was obtained in all 151 patients
with suspected pulmonary embolism at admission.
ECG’s were independently interpreted by two
observers blinded to patient data. Following ECG
signs were investigated: Heart rate >100 beats per
minute, rightward shift of QRS axis >50°, Qr in V1,
S1 subtypes (S1Q3/S1rSr#3/S1S2S3), incomplete and
complete right bundle branch block (RBBB), clock-
wise rotation of the QRS vector in the precordial
leads (CLOCKROT) defined as R=S in V4, V5 or V6, T
wave inversion in V2 or V3 (TNEGV2), ST elevation
in V1≥0.1mV (STPOSV1), and atrial fibrillation or
flutter.3,4,12,13 The criteria for the diagnosis of Qr in
V1 were the presence of a prominent Q wave of
≥0.2 mV and a ventricular depolarisation <120 ms
(Fig. 1).
Statistical analysis
Kappa measurement was performed to examine
interobserver agreement for ECG signs and spiral CT
findings, respectively. Stepwise logistic regression
was performed with univariately significant ECG
signs (Table 1) to find the best model to predict or
exclude pulmonary embolism. ProBNP levels in the
presence or absence of ECG signs were compared
with the Mann–Whitney u-test. Multivariate logistic
regression analysis was performed to investigate
the accuracy of ECG signs for predicting ‘escalation
of therapy’ defined as the need for cardiopul-
monary resuscitation, mechanical ventilation,
pressors, thrombolysis, catheter fragmentation, or
surgical embolectomy according to the MAPPET-3
criteria.14 Following univariately significant vari-
ables were included in the multivariate analysis:
Qr in V1, TNEGV2, Troponin I ≥0.06 ng/ml, proBNP
≥500 pg/ml, and moderate to severe right ventricu-
lar systolic dysfunction. Differences in mortality
and ‘escalation of therapy’ according to the pres-
ence or absence of ECG signs were analyzed using
Fisher’s exact two-sided test.
Results
ECG and pulmonary embolism diagnosis
Interobserver agreement was accurate for most
ECG signs (Table 2). Agreement for the presence or
Fig. 1 Twelve-lead ECG from a patient with acute pulmonary
embolism showing several signs of right ventricular strain: Qr in
V1, S1Q3, T wave inversion in V2, QRS axis >50°, clockwise
rotation of the QRS vectors in the precordial leads, heart rate of
100 beats per minute.
Table 1 Frequency of ECG signs in patients with and with-
out pulmonary embolism
ECG sign PE+
(n=75)
PE−
(n=76)
SE
(%)
SP
(%)
NPV
(%)
PPV
(%)
Heart rate
>100 bpm‡
28 13 37 83 44 68
Qr in V1
* 14 0 19 100 55 100
S1Q3/S1rSr#3/S1S2S3
† 50 28 67 50 40 64
Incomplete RBBB‡ 21 8 28 89 41 72
CLOCKROT 31 21 41 72 44 60
TNEGV2
‡ 21 9 26 88 41 70
STPOSV1
† 15 1 29 99 44 94
RBBB 2 4 3 95 51 33
QRS axis >50° 20 15 27 80 52 57
Atrial fibrillation 3 4 4 95 50 43
Atrial flutter 1 3 1 96 50 25
NPV=negative predictive value; PPV=positive predictive
value; SE=sensitivity; SP=specificity. CLOCKROT=clockwise
rotation of the QRS vector in the precordial leads; RBBB=right
bundle branch block; STPOSV1=ST elevation ≥0.1 mv in V1;
TNEGV2=T wave inversion in V2.
*p<0.0001
†p<0.001
‡p<0.05.
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absence of S1 subtypes and clockwise rotation
of the QRS vector in the precoardial leads was
moderately accurate.
None of the patients with excluded pulmonary
embolism had a Qr in V1 resulting in a specificity
and sensitivity of 100% and 19%, and a positive and
negative predictive value of 100% and 55%, respec-
tively. Sinus tachycardia, S1 subtypes, incomplete
RBBB, TNEGV2, and STPOSV1 were more frequently
present in patients with pulmonary embolism
(Table 1). None of the ECG signs was sufficiently
sensitive to exclude pulmonary embolism. The ac-
curacy to predict or exclude pulmonary embolism
was improved by the combination of Qr in V1,
STPOSV1, S1 subtypes, and incomplete RBBB result-
ing in a specificity and sensitivity of 91% and 47%,
respectively.
ECG signs in relation to right ventricular
strain and clinical outcome in patients with
pulmonary embolism
Moderate to severe right ventricular systolic
dysfunction by echocardiography was present in
42 patients with pulmonary embolism. Elevated
Troponin I levels were found in 25 patients with
pulmonary embolism. Nine of 14 patients with Qr in
V1 and 10 of 15 patients with STPOSV1 had a troponin
I level ≥0.6 ng/ml (Table 3). Significant differences
in proBNP levels were found for Qr in V1, iRBBB,
CLOCKROT, and TNEGV2 (Fig. 2). Qr in V1 and TNEGV2
were most specific for the prediction of right ven-
tricular dysfunction, and S1 subtypes most sensitive
for the exclusion of right ventricular dysfunction
compared with other ECG signs (Table 4).
In patients with a shock index ≥1 (heart rate
divided by systolic blood pressure) and right ven-
tricular dysfunction, thrombolysis was performed in
six and surgical embolectomy in four patients.
Thrombolysis was also administered in six patients
with a shock index <1 and right ventricular dys-
function. Heparin alone was given in the remaining
59 patients of whom 26 had right ventricular
dysfunction but contraindications for thrombolysis
according to the guidelines of the European Society
of Cardiology.15
Five of the 75 patients with pulmonary embolism
died in-hospital from right ventricular failure.
Twenty patients had ‘escalation of therapy’ includ-
ing the need for at least one of the following:
cardiopulmonary resuscitation (n=3), mechanical
ventilation (n=4), pressors (n=7), thrombolysis
(n=12), embolectomy (n=4). In patients with
‘escalation of therapy’, systolic blood pressure was
lower (89±27 vs 122±19 mmHg; p=0.011), and heart
rate higher (114±20 vs 85±17 beats per minute;
p=0.023) compared to patients without the need
for ‘escalation of therapy’.
Qr in V1 was present in three (60%) of the five
patients who died from right ventricular failure,
and it was present in only 11 of 67 (16%) surviving
patients (Table 5). Compared with other ECG signs,
sinus tachycardia, Qr in V1 and TNEGV2 also pre-
dicted ‘escalation of therapy’. Sensitivity, speci-
ficity, negative and positive predictive value of Qr
in V1 for predicting ‘escalation of therapy’ were
55%, 95%, 85% and 79%, respectively. In a multivari-
ate regression analysis including the ECG signs Qr in
V1 and TNEGV2, results of echocardiography and bio-
marker tests, Qr in V1 (OR 8.7, 95%CI 1.4–56.7;
p=0.02), proBNP levels ≥500 pg/ml (OR 12.5, 1.2–
135.2; p=0.04), and Troponin I levels ≥0.06 ng/ml
(OR 7.7, 1.6–36.5; p=0.01) remained independent
predictors of adverse clinical outcome. Sensitivity,
specificity, negative and positive predictive value
of the combination of these prognostic markers for
the prediction of ‘escalation of therapy’ were 75%,
91%, 75% and 91%, respectively.
DISCUSSION
ECG and pulmonary embolism diagnosis
The present study of 151 patients with suspected PE
confirms previous reports that ECG alone is not
sufficient to exclude pulmonary embolism.2–4,16
Sensitivity and specificity of ECG to predict pul-
monary embolism even in combination of different
ECG signs (i.e. Qr in V1, STPOSV1, S1 subtypes, and
incomplete RBBB) was 47% and 91%, respectively.
The prevalence of Q waves in V1 among patients
with pulmonary embolism in the present study
Table 2 Interobserver agreement for ECG findings in
patients with suspected pulmonary embolism
ECG sign Agreement (%) Kappa*
Qr in V1 98.7 0.92
S1Q3/S1rSr#3/S1S2S3 89.4 0.79
Incomplete RBBB 90.1 0.68
RBBB 98.7 0.83
CLOCKROT 85.4 0.66
TNEGV2 92.1 0.71
STPOSV1 99.3 0.97
QRS axis >50° 93.2 0.73
Atrial fibrillation 100.0 1.00
Atrial flutter 100.0 1.00
*p<0.0001 for all kappa measurements. CLOCKROT=
clockwise rotation of the QRS vector in the precordial leads;
RBBB=right bundle branch block; STPOSV1=ST elevation
≥0.1 mv in V1; TNEGV2=T wave inversion in V2.
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(19%) was similar in the study of Weber et al. (17%)
and Stein et al. (11%).3,4 Due to a lack of a control
group in the above mentioned studies, no state-
ment about the diagnostic accuracy of this ECG sign
was possible. In the present study, none of the 76
patients with excluded PE presented with a Qr in V1
resulting in a specificity and positive predictive
value of 100%, respectively.
ECG signs in relation to right ventricular
strain and clinical outcome in patients with
pulmonary embolism
The relation of ECG signs indicating right ventricu-
lar strain with haemodynamic data is well
documented.4,17–19 In 90 patients with pulmonary
embolism, those with pseudoinfarction pattern
(29±3 mmHg) and right axis deviation (31±7 mmHg)
had highest mean pulmonary artery pressure
values.4 In a study of 80 patients with pulmonary
embolism, TNEGV2 was associated with severely
increased mean pulmonary artery pressure
(37±8 mmHg) compared with the other ECG signs.17
In the present study, QR in V1 and TNEGV2 were most
closely related to the presence of moderate to
severe right ventricular dysfunction.
Pulmonary artery pressure is probably not the
best outcome predictor because it depends on
dynamics of embolic events, right ventricular
systolic function and volume status. Thus, patients
with chronic recurrent pulmonary embolism will
probably tolerate higher pulmonary artery pressure
values than those with a single massive embolic
event. Novel and probably more accurate predic-
tors of right ventricular dysfunction include mark-
ers of minor myocardial injury (cardiac troponins)
and increased myocardial shear stress (b-type and
atrial natriuretic peptides).20–23 In the present
study, STPOSV1 and Qr in V1 were the only ECG signs
associated with the presence of a troponin I leak.
High proBNP levels were found in patients with Qr
in V1, TNEGV2, incomplete RBBB, and clockwise
rotation of the QRS vector in the precordial leads.
Qr in V1 was associated with increased early
mortality. Three of five patients who died in-
hospital from right ventricular failure initially pre-
sented with this sign. In addition, Qr in V1 and
TNEGV2 were highly associated with an increased
risk of ‘escalation of therapy’ including the need
for cardiopulmonary resuscitation, mechanical ven-
tilation, pressors, thrombolysis, or embolectomy.
After adjustment for the emerging markers of right
ventricular strain including ECG signs, echocardio-
graphic findings, troponin I and proBNP levels, Qr
in V1 remained an independent predictor of
‘escalation of therapy’.
Despite interpretation of negative spiral CT
scans in context with clinical pretest probability,
and the absence of venous thromboembolism
among 46 patients with initially negative test re-
sults during follow-up, pulmonary embolism could
have been present in a few cases. This might have
Table 3 ECG signs according to the presence or absence of a Troponin I leak in 75 patients with pulmonary embolism
ECG sign positive* Troponin I≥0.6 ng/ml(n=25) Troponin I<0.6 ng/ml(n=50) p
Heart rate >100 bpm 13(52) 15(39) ns
Qr in V1 9(36) 5(19) 0.008
S1Q3/S1rSr#3/S1S2S3 19(76) 31(62) ns
Incomplete RBBB 10(40) 11(22) ns
CLOCKROT 15(65) 16(32) 0.01
TNEGV2 11(48) 10(20) 0.03
STPOSV1 10(40) 5(10) 0.002
QRS axis >50° 10(40) 10(20) 0.05
*For abbreviations see footnote in Table 1
Fig. 2 Box plots showing logarithmic pro-brain natriuretic pep-
tide levels in the presence or absence of ECG signs in 75 patients
with pulmonary embolism. Boxes with error bars represent
median values, 10th, 25th, 75th, and 90th percentiles.
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caused overestimation of sensitivity of the ECG
signs, thus making it even lower than reported in
the present study.
Conclusion
Qr in V1 is highly specific for pulmonary embolism
although its prevalence among consecutive
patients with suspected pulmonary embolism is
low. Compared with other ECG signs, Qr in V1 is the
strongest predictor of right ventricular dysfunction,
and it is highly associated with troponin leakage
and myocardial shear stress. Qr in V1 and the pres-
ence of negative T waves in V2 or V3 also predict
a complicated hospital course and therefore, are
useful for risk stratification in pulmonary embo-
lism. In patients with suspected acute pulmonary
embolism, presenting with one of these ECG
signs, more intensive hospital resources should be
allocated to allow for a rapid diagnostic approach
including echocardiography to confirm right
ventricular dysfunction.
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